XML 150 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Total Lisata Therapeutics, Inc. Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Non- Controlling Interest in Subsidiary
Beginning Balance (in shares) at Dec. 31, 2021     3,986,000          
Beginning Balance at Dec. 31, 2021 $ 92,000 $ 92,254 $ 4 $ 546,044 $ (70) $ (453,016) $ (708) $ (254)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (54,225) (54,225)       (54,225)    
Share-based compensation (in shares)     97,000          
Share-based compensation 2,367 2,367   2,367        
Net proceeds from issuance of common stock and warrants (in shares)     11,000          
Net proceeds from issuance of common stock 43 43   43        
Issuance of common stock in connection with Merger (in shares)     3,773,000          
Issuance of common stock in connection with Merger 26,098 26,098 $ 4 26,094        
Unrealized loss on marketable securities 52 52     52      
Foreign currency translation adjustment (11)       (11)      
Ending Balance (in shares) at Dec. 31, 2022     7,867,000          
Ending Balance at Dec. 31, 2022 66,324 66,578 $ 8 574,548 (29) (507,241) (708) (254)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (20,840) (20,840)       (20,840)   0
Share-based compensation (in shares)     114,000          
Share-based compensation 1,947 1,947   1,947        
Net proceeds from issuance of common stock and warrants (in shares)     87,000          
Net proceeds from issuance of common stock $ 321 321   321        
Proceeds from option exercises (in shares) 82,500   83,000          
Proceeds from option exercises $ 155 155   155        
Unrealized loss on marketable securities 12 12     12      
Foreign currency translation adjustment (25)       (25)      
Ending Balance (in shares) at Dec. 31, 2023     8,151,000          
Ending Balance at Dec. 31, 2023 $ 47,894 $ 48,148 $ 8 $ 576,971 $ (42) $ (528,081) $ (708) $ (254)